Overall survival (OS) in BRCA-mutated breast cancer improved significantly with the addition of olaparib (Lynparza) to ...

In a small study of early-stage breast cancer patients with BRCA gene mutations, researchers from the University of Cambridge ...

Researchers conducted a retrospective multicenter cohort study analyzing 575 female patients with BRCA1 or BRCA2 pathogenic ...

Combination treatment with a PARP inhibitor and an anti-angiogenic agent did not improve PFS when compared to chemotherapy or a PARP inhibitor alone.

Olaparib, which is taken as tablets, is already available on the NHS. A class of cancer drug known as a PARP inhibitor, it ...

Over the course of his 18-month battle with cancer, Becker’s father discovered he had the BRCA gene, a rare mutation that’s known to increase breast and ovarian cancer in women by an estimated 55% to ...

BRCA mutation carriers opting for prophylactic risk-reducing salpingo-oophorectomy (RRSO) face potential impacts on sexual functioning and body image.The aim of the study was to assess the extent of ...

Those with the Angelina Jolie mutation can do just like her and remove female organs to have a profound reduction in cancer ...

A panelist discusses how multiple molecular biomarkers beyond BRCA and homologous recombination deficiency (HRD) testing are ...

World Ovarian Cancer Day is observed every year on May 8 to increase awareness about this dreaded disease, which mostly goes undiagnosed in women. Also known as a “silent killer,” ovarian cancer ...

Frida Giannini, former creative director of Gucci, shared her personal experience regarding discovering she carries the BRCA ...